Home to the Schaeffer Center for Health Policy & Economics and the Schaeffer Fellows in Government Service. Transforming policy through rigorous, independent research and close engagement with public and private sector leaders.
USC Schaeffer
Loading...
Medicare could unlock a trove of valuable clinical trial data through relatively modest changes to reporting requirements, USC Schaeffer Scholars Sidra Haye and Mireille Jacobson write in @jamahealthforum.com.
USC Schaeffer's Erin Duffy shares why reviewing medical bills closely can make a real difference for patients facing unexpected charges.
GLP-1s may deliver the greatest health and economic benefits to disadvantaged populations, who historically have faced greater barriers to sustained weight loss through behavioral interventions.
New NBER working paper from USC Schaeffer scholars ⬇️
"The United States has already invested in developing curative therapies. Without a financing model that matches their value, those cures will remain out of reach for many patients," writes USC Schaeffer's William Padula in @statnews.com.
"Even if you live in a wealthy country, if you lack access to clean drinking water, you are far more likely to lack access to food."
-USC Schaeffer's Wandi Bruine de Bruin on her new research linking food insecurity & water insecurity.
Today’s near-retirees are healthier and more capable than ever. For those who are able to, choosing to work just one more year can improve their well-being & America's fiscal outlook.
New @thehill.com op-ed from USC Schaeffer Founding Director Dana Goldman & CMS Chief Economist Anup Malani.⬇️
Cell and gene therapies are transforming medicine, but significant questions remain about cost, reimbursement & access. Hear USC Schaeffer's Darius Lakdawalla break down these issues in tomorrow's webinar from @mhexecutive.bsky.social.
✒️Registration: globalmeet.webcasts.com/starthere.js...
Medicare’s cap on monthly #insulin costs reduced beneficiaries’ spending on the drug by 21% and increased use among those who previously had especially high costs, finds new USC Schaeffer research in JAMA.
A proposed California ballot measure to cap medical executives' pay is unlikely to reduce patient costs, USC Schaeffer's Glenn Melnick tells @kffhealthnews.org.
At yesterday's FDA listening session on the commissioner's voucher program, USC Schaeffer's Lowell Schiller said issuing formal rules or guidance would strengthen program integrity and provide greater certainty for product sponsors.
USC Schaeffer
More accurate reporting of trial-related care could generate valuable evidence about new treatments, promote representative trial enrollment and improve coverage decisions. - June 12, 2026
GLP-1s may deliver the greatest health and economic benefits to disadvantaged populations, who historically have faced greater challenges losing weight through behavioral interventions. - June 8, 2026
People who keep working into their 60s report more purpose and stronger social ties.
thehill.com
A landmark study spanning 121 countries has found that people without access to clean drinking water are pointedly more likely to go hungry, a link that...
The monthly spending limit improved adherence among insulin users who previously had especially high costs, Schaeffer researchers found. - June 8, 2026
schaeffer.usc.edu
FDA should establish clear rules or guidance outlining how products are selected and evaluated for the program, along with appropriate guardrails. - June 4, 2026
One of California’s largest healthcare unions is sponsoring two initiatives that would regulate community clinics and cap executive and managerial pay at hospitals and physician groups. In the most re...
